These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 365487)

  • 1. [Amikacin and gentamicin: a controlled comparison (author's transl)].
    Höffler D
    Dtsch Med Wochenschr; 1978 Dec; 103(52):2071-5. PubMed ID: 365487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the local use of amikacin].
    Wada S; Nishio S; Kishimoto T; Maekawa M; Yuki K; Sasaki S; Oshima N; Hayahara N; Nishijima T; Funai K
    Hinyokika Kiyo; 1985 May; 31(5):907-13. PubMed ID: 4050636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin in the treatment of pyelonephritis.
    Höffler D
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):386-91. PubMed ID: 387619
    [No Abstract]   [Full Text] [Related]  

  • 8. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amikacin in urinary tract infections with so-called problem pathogens].
    Hofstetter A; Staehler G
    Fortschr Med; 1976 Aug; 94(24):1305-8. PubMed ID: 786834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
    Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
    Wielunsky E; Drucker M; Cohen T; Reisner SH
    Isr J Med Sci; 1983 Nov; 19(11):1006-8. PubMed ID: 6662682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amikacin Therapy of Urinary tract infections.
    Cox CE
    J Infect Dis; 1976 Nov; 134 SUPPL():S362-8. PubMed ID: 792358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL
    Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amikacin and gentamicin in the treatment of urinary tract infections.
    Gilbert DN; Eubanks N; Jackson J
    Am J Med; 1977 Jun; 62(6):924-9. PubMed ID: 868907
    [No Abstract]   [Full Text] [Related]  

  • 20. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.